Item talk:Q168092: Difference between revisions
From geokb
(Added OpenAlex topic data) |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
"id": "https://openalex.org/T11280", | |||
"display_name": "Management and Treatment of Hemophilia", | |||
"description": "This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.", | |||
"keywords": [ | |||
"Hemophilia", | |||
"Factor VIII", | |||
"Prophylaxis", | |||
"Inhibitors", | |||
"Recombinant Factor VIIa", | |||
"Gene Therapy", | |||
"Joint Disease", | |||
"Coagulation Disorders", | |||
"Efficacy", | |||
"Safety" | |||
id: https://openalex.org/ | ], | ||
"ids": { | |||
"openalex": "https://openalex.org/T11280", | |||
"wikipedia": "https://en.wikipedia.org/wiki/Hemophilia_management" | |||
}, | |||
"subfield": { | |||
"id": "https://openalex.org/subfields/2720", | |||
"display_name": "Hematology" | |||
}, | |||
"field": { | |||
"id": "https://openalex.org/fields/27", | |||
"display_name": "Medicine" | |||
}, | |||
"domain": { | |||
"id": "https://openalex.org/domains/4", | |||
"display_name": "Health Sciences" | |||
}, | |||
id: https://openalex.org/ | "siblings": [ | ||
{ | |||
id: https://openalex.org/ | "id": "https://openalex.org/T10309", | ||
"display_name": "Acute Myeloid Leukemia" | |||
id: https://openalex.org/ | }, | ||
{ | |||
id: https://openalex.org/ | "id": "https://openalex.org/T10649", | ||
"display_name": "Diagnosis and Treatment of Multiple Myeloma" | |||
id: https://openalex.org/ | }, | ||
{ | |||
id: https://openalex.org/ | "id": "https://openalex.org/T11660", | ||
"display_name": "Diseases Related to Blood Group Variants" | |||
id: https://openalex.org/ | }, | ||
{ | |||
id: https://openalex.org/ | "id": "https://openalex.org/T11215", | ||
"display_name": "Efficacy and Resistance in CML Treatment" | |||
id: https://openalex.org/ | }, | ||
{ | |||
id: https://openalex.org/ | "id": "https://openalex.org/T10345", | ||
"display_name": "Hematopoietic Stem Cell Biology" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T11616", | |||
"display_name": "Hemophagocytic Lymphohistiocytosis and Related Disorders" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T12548", | |||
"display_name": "Hemostatic Agents and Techniques" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10746", | |||
"display_name": "Platelet Disorders and Thrombosis Mechanisms" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10452", | |||
"display_name": "Regulation of Iron Metabolism and Anemia" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T11534", | |||
"display_name": "Role of Erythropoietin in Disease Treatment and Management" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10881", | |||
"display_name": "Thrombosis and Coagulation Disorders" | |||
} | |||
], | |||
"works_count": 39708, | |||
"cited_by_count": 513035, | |||
"updated_date": "2024-08-26T05:22:20.118696", | |||
"created_date": "2024-01-23" | |||
} |
Revision as of 14:10, 30 August 2024
{
"id": "https://openalex.org/T11280", "display_name": "Management and Treatment of Hemophilia", "description": "This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.", "keywords": [ "Hemophilia", "Factor VIII", "Prophylaxis", "Inhibitors", "Recombinant Factor VIIa", "Gene Therapy", "Joint Disease", "Coagulation Disorders", "Efficacy", "Safety" ], "ids": { "openalex": "https://openalex.org/T11280", "wikipedia": "https://en.wikipedia.org/wiki/Hemophilia_management" }, "subfield": { "id": "https://openalex.org/subfields/2720", "display_name": "Hematology" }, "field": { "id": "https://openalex.org/fields/27", "display_name": "Medicine" }, "domain": { "id": "https://openalex.org/domains/4", "display_name": "Health Sciences" }, "siblings": [ { "id": "https://openalex.org/T10309", "display_name": "Acute Myeloid Leukemia" }, { "id": "https://openalex.org/T10649", "display_name": "Diagnosis and Treatment of Multiple Myeloma" }, { "id": "https://openalex.org/T11660", "display_name": "Diseases Related to Blood Group Variants" }, { "id": "https://openalex.org/T11215", "display_name": "Efficacy and Resistance in CML Treatment" }, { "id": "https://openalex.org/T10345", "display_name": "Hematopoietic Stem Cell Biology" }, { "id": "https://openalex.org/T11616", "display_name": "Hemophagocytic Lymphohistiocytosis and Related Disorders" }, { "id": "https://openalex.org/T12548", "display_name": "Hemostatic Agents and Techniques" }, { "id": "https://openalex.org/T10746", "display_name": "Platelet Disorders and Thrombosis Mechanisms" }, { "id": "https://openalex.org/T10452", "display_name": "Regulation of Iron Metabolism and Anemia" }, { "id": "https://openalex.org/T11534", "display_name": "Role of Erythropoietin in Disease Treatment and Management" }, { "id": "https://openalex.org/T10881", "display_name": "Thrombosis and Coagulation Disorders" } ], "works_count": 39708, "cited_by_count": 513035, "updated_date": "2024-08-26T05:22:20.118696", "created_date": "2024-01-23"
}